Conditions: Hepatocellular Carcinoma (HCC); Bone Metastases
Interventions: Drug: Denosumab; Drug: Sintilimab; Other: Delayed/Rescue Bone-Modifying Strategy
Sponsors: Tongji Hospital
Not yet recruiting Conditions: Hepatocellular Carcinoma (HCC); Bone Metastases
Interventions: Drug: Denosumab; Drug: Sintilimab; Other: Delayed/Rescue Bone-Modifying Strategy
Sponsors: Tongji Hospital
Not yet recruiting
